It seems like the era of Japanese Dodges and Chinese Chevies wasn't that long ago. Why aren't American automakers rebadging ...

In the UK, the 300ZX never reached the dominant position it did in the USA, instead looking pricey in a market full of lithe coupés better suited to the twisty roads of the old world – cars such as ...

Mitsubishi Tanabe saw core operating income slide 61% to 56.2 billion yen ($370 million) in the last financial year. Private equity-led buyouts are booming in Japan as companies increasingly carve ...

TOKYO: Japan's Mitsubishi Corp took a ¥66.8 billion (US$438.61 million) impairment charge on its domestic offshore wind projects in the nine-month period ended in December, it said on Thursday.

Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...

Mitsubishi Corp (TSE: 8058) has taken a 52.2 billion yen ($342.4 million) impairment charge on its offshore wind projects, ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Mitsubishi logo, is seen on a car during the 89th Geneva Motorshow. Uli Deck/dpa Profit rose in the nine-month period from April to December 2024 for Japanese conglomerate Mitsubishi compared tot ...